By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.


Aetna/CVS Decision Imminent

A decision from the Department of Justice regarding CVS Health’s $69 billion acquisition of Aetna is expected before noon onfeatured

Aetna/CVS: Connecticut Public Hearing and States Update

Updated with Maryland Approval – On the sidelines of the Connecticut Insurance Department Form A hearing regarding CVS Health’s $69 billion acquisition of Aetna, CVS general counsel Tom Moriarty told CTFN the parties are making good progress with the pending antitrust reviewfeatured

Peritoneal Divestiture Also Required in Fresenius Acquisition of NxStage

The review by the U.S. Federal Trade Commission of the acquisition of NxStage by Fresenius is on track and moving forward, according to a source familiar with the matter.featured

Linde/Praxair One Step Closer to Completing Merger

The Korea Fair Trade Commission on October 3 issued a preliminary approval with additional demands for the Linde/Praxair merger, another step forward for the $83 billion transaction.featured

Precedents Suggest a Decision Relatively Soon by California DMHC on Aetna/CVS Merger

Historical precedent suggests that the Aetna/CVS review by California’s Department of Managed Health Care could be completed before year end, while a typical timeline for reviews of large company mergers by DMHC suggests the review offeatured

Aetnas Agreement to Sell its Medicare Part D Business Viewed Positively

Aetna announced September 27 that it had entered into an agreement for WellCare to acquire all of Aetna’s standalone Medicare Part D prescription drug plan business effective December 31,featured

California Developments Regarding Express Scripts/Cigna and Aetna/CVS

On September 26 a public meeting will be conducted by the California Department of Managed Health Care pertaining to the acquisition of Express Scripts by Cigna.featured

Update: Aetna/CVS State Insurance Department Reviews

The Connecticut Department of Insurance, the lead state insurance commission examining the $69 billion Aetna/CVS transaction, will hold a public hearing on October 4.featured

Linde/Praxair Pieces Appear to Fall into Place with FTC Review

The U.S. Federal Trade Commission’s decision on the $45 billion Linde/Praxair transaction could come soon, according to a person close to the situation.featured

LyondellBasell is the Likely Buyer of Linde’s La Porte Plant

Linde’s HYCO plant in La Porte, Texas, along with employee contracts are going to be sold to LyondellBasell as Linde/Praxair aim to save their multi-billion merger, a person with knowledge of the matter told CTFN.featured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.